Page last updated: 2024-10-22

altretamine and Adenocarcinoma, Papillary

altretamine has been researched along with Adenocarcinoma, Papillary in 2 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Phenytoin levels were reduced to 37% of the original values, although the drug was given intravenously."1.27An interaction between cytostatic and anticonvulsant drugs. ( de Voogd-van der Straaten, I; Neef, C, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tempero, MA1
Kessinger, A1
Neef, C1
de Voogd-van der Straaten, I1

Other Studies

2 other studies available for altretamine and Adenocarcinoma, Papillary

ArticleYear
Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.
    Journal of surgical oncology, 1982, Volume: 21, Issue:3

    Topics: Adenocarcinoma, Papillary; Aged; Altretamine; Drug Therapy, Combination; Female; Humans; Melphalan;

1982
An interaction between cytostatic and anticonvulsant drugs.
    Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:4

    Topics: Adenocarcinoma, Papillary; Adult; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carba

1988